Mpox in Ghana: Cases Near 1,000 as Vaccination Campaign Begins
Ghana's Mpox outbreak has entered a critical new phase. As of late January 2026, confirmed cases have surged to nearly 1,000, with seven fatalities recorded and a nationwide vaccination campaign now underway. This article provides a comprehensive, data-driven update on the current situation, government response, and what you need to know to stay safe.
Current Situation: Cases Surge, Death Toll Rises
The Ghana Health Service (GHS) has confirmed 993 total Mpox cases as of January 25, 2026, with 13 new infections reported in the final week of the month. The outbreak has now spread to all 16 administrative regions, marking a significant escalation from mid-2025 when only 14 regions were affected.
Tragically, the national death toll has risen to seven, with health authorities confirming no new fatalities in recent weeks but emphasizing that vigilance remains critical. The Western Region currently reports 59 active cases across 13 districts, making it a particular hotspot.
Vaccination Campaign: A Turning Point in the Response
In a major development, Ghana has received its first batch of 20,000 Mpox vaccine doses, approved by the Food and Drugs Authority (FDA), and has launched a targeted 21-day vaccination exercise.
The campaign, initiated in the Western Region, follows a two-phase strategy:
- Intensive Phase (4 days): Focused vaccination in the most affected communities.
- Normal Delivery Phase (17 days): Broader distribution across high-risk districts.
Acting Director-General of the GHS, Dr. Samuel Kaba Akoriyea, has stressed the urgency: "Our newest hope is the vaccination; we cannot afford to lose people to this preventable condition." . Health workers, close contacts of confirmed cases, and residents in seven high-risk districts are the initial priority groups.
Government and Partner Response
The Ghana Health Service, supported by the World Health Organization (WHO) and other partners, has intensified multiple response pillars:
- Surveillance & Contact Tracing: Regional health directorates have enhanced monitoring, particularly in Greater Accra, Western, and Ashanti regions.
- Workforce Training: Over 1,800 clinicians and health staff have been trained in surveillance and case management
- Community Engagement: Public awareness campaigns are emphasizing early reporting, hygiene, and dispelling myths (e.g., "bathing with sea water cannot cure Mpox")
Dr. Frank Lule, representing WHO, confirmed that the African region has recorded 30,000 confirmed cases and 120 deaths, and reaffirmed WHO's commitment to providing technical and operational support to Ghana's efforts
Symptoms, Transmission, and Protection
Mpox, caused by the monkeypox virus, presents with distinct symptoms and spreads through specific pathways.
Common Symptoms
- Fever, headache, muscle aches, and chills
- Swollen lymph nodes (a distinguishing feature from smallpox)
- Characteristic rash that progresses through macules, papules, vesicles, pustules, and crusting stages
- Fatigue and tiredness
How It Spreads
- Direct physical contact with an infected person's rash, scabs, or body fluids
- Respiratory droplets during prolonged face-to-face contact
- Contaminated materials (bedding, clothing, towels)
- Mother to fetus during pregnancy or to newborn during/after birth
Protect Yourself and Your Community
- Avoid close contact with anyone showing Mpox symptoms
- Wash hands regularly with soap and water or use alcohol-based sanitizer
- Report symptoms immediately to the nearest health facility early detection saves lives
- If eligible, get vaccinated when the vaccine becomes available in your district
- Do not rely on unproven remedies; seek professional medical care
Regional and Continental Context
Ghana's outbreak reflects broader trends in West Africa. The U.S. CDC issued a Level 2 Travel Health Notice on January 26, 2026, confirming outbreaks of clade II monkeypox in both Ghana and Liberia, and recommending vaccination for travelers.
However, there is positive news at the continental level. On January 22, 2026, the Africa Centres for Disease Control and Prevention (Africa CDC) lifted its Public Health Emergency of Continental Security declaration for mpox, citing "improvements in country capacity, effective international partnerships, a sustained decline in reported cases, and a reduction in case fatality rates" . This signals a transition "from emergency response to a sustained, country-led pathway toward elimination" .
Conclusion: Vigilance Remains Essential
Ghana's Mpox outbreak is at a pivotal juncture. While the arrival of vaccines and the Africa CDC's lifted emergency declaration are positive developments, the continued spread of the virus now in all 16 regions with nearly 1,000 confirmed cases demands sustained public vigilance and cooperation.
The tools for control are now available: vaccines, trained health workers, and proven public health measures. Their effectiveness depends entirely on community participation, early reporting, and trust in science and health authorities. The seven lives lost are a solemn reminder that this preventable disease remains a serious threat. Every individual's actions matter.
Join the Discussion
Have you or someone in your community been affected by the Mpox outbreak? What questions do you still have about the virus, vaccine, or public health measures? Share your experiences and concerns respectfully in the comments your voice helps build community awareness.
Sources & Verified Information
- Ghana Health Service (GHS): Official updates via @_GHSofficial on X
- World Health Organization (WHO): Mpox situation reports and technical guidance
- Africa Centres for Disease Control and Prevention (Africa CDC): Emergency declaration updates
- U.S. Centers for Disease Control and Prevention (CDC): Travel Health Notices
Recommended Reads on VoltFeed
- Devastating Torrential Rains and Their Impact in South Korea
- Understanding Public Health Emergencies: How Ghana Responds
About the Writer
Zakaria Abdul-Rafiu is a writer and Forest Resource Technology student at KNUST who is committed to accurate, responsible health and science communication. At VoltFeed, he prioritizes verified information from authoritative sources to help readers make informed decisions during public health events.
Have a health topic you'd like us to investigate and explain? Submit your suggestions in the comments.